These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

45 related items for PubMed ID: 1864630

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Hypertriglyceridemia as a result of human apo CIII gene expression in transgenic mice.
    Ito Y, Azrolan N, O'Connell A, Walsh A, Breslow JL.
    Science; 1990 Aug 17; 249(4970):790-3. PubMed ID: 2167514
    [Abstract] [Full Text] [Related]

  • 8. Human apoA-I/C-III/A-IV gene cluster transgenic rabbits: effects of a high-cholesterol diet.
    Recalde D, Baroukh N, Viglietta C, Prince S, Verona J, Vergnes L, Pidoux J, Nazeem Nanjee M, Brites F, Ochoa A, Castro G, Zakin MM, Miller NE, Marie Houdebine L.
    FEBS Lett; 2004 Aug 13; 572(1-3):294-8. PubMed ID: 15304365
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Endogenous hypertriglyceridemia].
    Kotake H, Oikawa S.
    Nihon Rinsho; 2001 Mar 13; 59 Suppl 3():63-8. PubMed ID: 11347144
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Common genetic variation in the promoter of the human apo CIII gene abolishes regulation by insulin and may contribute to hypertriglyceridemia.
    Li WW, Dammerman MM, Smith JD, Metzger S, Breslow JL, Leff T.
    J Clin Invest; 1995 Dec 13; 96(6):2601-5. PubMed ID: 8675624
    [Abstract] [Full Text] [Related]

  • 13. Reversal of hyperlipidaemia in apolipoprotein C1 transgenic mice by adenovirus-mediated gene delivery of the low-density-lipoprotein receptor, but not by the very-low-density-lipoprotein receptor.
    Jong MC, van Dijk KW, Dahlmans VE, Van der Boom H, Kobayashi K, Oka K, Siest G, Chan L, Hofker MH, Havekes LM.
    Biochem J; 1999 Mar 01; 338 ( Pt 2)(Pt 2):281-7. PubMed ID: 10024503
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Apolipoprotein C-III protein concentrations and gene polymorphisms in Type 1 diabetes: associations with microvascular disease complications in the DCCT/EDIC cohort.
    Klein RL, McHenry MB, Lok KH, Hunter SJ, Le NA, Jenkins AJ, Zheng D, Semler A, Page G, Brown WV, Lyons TJ, Garvey WT, DCCT/EDIC Research Group.
    J Diabetes Complications; 2005 Mar 01; 19(1):18-25. PubMed ID: 15642486
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Fibrates downregulate apolipoprotein C-III expression independent of induction of peroxisomal acyl coenzyme A oxidase. A potential mechanism for the hypolipidemic action of fibrates.
    Staels B, Vu-Dac N, Kosykh VA, Saladin R, Fruchart JC, Dallongeville J, Auwerx J.
    J Clin Invest; 1995 Feb 01; 95(2):705-12. PubMed ID: 7860752
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. PvuII polymorphic site upstream to the human ApoCIII gene.
    Oettgen P, Antonarakis SE, Karathanasis SK.
    Nucleic Acids Res; 1986 Jul 11; 14(13):5571. PubMed ID: 3016655
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 3.